This patient was a 72-year-old woman who was initially diagnosed in 2012 with de novo hormone-receptor negative, HER2-positive (IHC 3+) metastatic breast cancer to mediastinal lymph nodes. This evidence concerns the gene ERBB2 and breast carcinoma.